Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080–1088.

    Article  CAS  Google Scholar 

  2. Heintel D, Kienle D, Shehata M, Krober A, Kroemer E, Schwarzinger I et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216–1223.

    Article  CAS  Google Scholar 

  3. Bomben R, Dal BM, Capello D, Benedetti D, Marconi D, Zucchetto A et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood 2007; 109: 2989–2998.

    CAS  PubMed  Google Scholar 

  4. Tobin G, Thunberg U, Johnson A, Thorn I, Soderberg O, Hultdin M et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262–2264.

    Article  CAS  Google Scholar 

  5. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678–1685.

    Article  CAS  Google Scholar 

  6. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56–63.

    CAS  PubMed  Google Scholar 

  7. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007; 109: 259–270.

    Article  CAS  Google Scholar 

  8. Del Principe MI, Del PG, Buccisano F, Maurillo L, Venditti A, Zucchetto A et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006; 108: 853–861.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by Ministero della Salute (Ricerca Finalizzata IRCCS and ‘Alleanza Contro il Cancro’), Rome; Programmi di Ricerca di Interesse Nazionale (PRIN) and Fondo per gli Investimenti per la Ricerca di Base (FIRB), MUR, Rome; Associazione Italiana contro le Leucemie linfomi e mielomi (AIL)—Venezia, Pramaggiore group (fellowship to MDB); Novara-AIL Onlus, Novara; Ricerca Scientifica Applicata Regione Piemonte, Torino.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Gattei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benedetti, D., Bomben, R., Dal-Bo, M. et al. Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10. Leukemia 22, 224–226 (2008). https://doi.org/10.1038/sj.leu.2404867

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404867

Search

Quick links